Etonogestrel Synthesis via Selective 11-Ketone Oxidation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current synthesis routes for etonogestrel and desogestrel in hormonal contraceptives are labor-intensive and costly, lacking efficient and cost-effective alternatives.

Innovation Solution

A process involving the synthesis of 20-yn-11-methylene-3-dithioacetal steroid derivatives using deprotection with periodic acid, thallium nitrate, or stabilized 2-iodoxybenzoic acid and β-cyclodextrin, reducing the complexity and cost of producing etonogestrel and desogestrel.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If conventional synthesis routes are used for etonogestrel and desogestrel, then the products can be manufactured, but the process is labor-intensive and costly

Engineering Contradiction:
Improvemanufacturing efficiencyVSAvoidproduction cost
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The synthesis route is divided into distinct modular stages: oxidation of 11β-hydroxy-18-methylnordione to the triketone, selective protection of carbonyl groups as ethylene acetals, deprotection to yield the 11-keto derivative, and final conversion to etonogestrel or desogestrel. Each stage is optimized independently, improving overall manufacturing efficiency while controlling costs through targeted intermediate isolation and reuse of reagents.

Inventive Principle:
Principle #1Segmentation

2Manufacturing precision

If selective protection of carbonyl groups is performed, then the 11-ketone can be obtained, but the process requires multiple protection and deprotection steps

Engineering Contradiction:
ImproveselectivityVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

Ethylene glycol is used as a protecting group intermediary to selectively mask the 3-keto and 17-keto carbonyl groups as ethylene acetal derivatives during the oxidation step. This allows selective formation of the 11-ketone functionality. The protecting group is then cleanly removed under acidic conditions to yield the desired 11-keto-3,17-diol intermediate, demonstrating high selectivity despite the multi-step nature of the process.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The oxidation conditions are carefully controlled by adjusting parameters such as the oxidant type (sodium periodate, TEMPO), solvent composition (acetonitrile/water mixtures), temperature, and pH. These parameter optimizations enable selective oxidation at the C-11 position while minimizing side reactions, achieving high manufacturing precision even through multiple steps.

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If multiple synthesis steps are used for introducing 11-functionality, then the desired steroid derivative can be obtained, but five steps are required

Engineering Contradiction:
Improvefunctional group introductionVSAvoidnumber of steps
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The 3-keto and 17-keto groups are pre-protected as ethylene acetals before the oxidation step. This preliminary protection prevents unwanted oxidation at these positions and directs the oxidant specifically to the C-11 hydroxyl group. By preparing the molecule in advance with appropriate protecting groups, the subsequent oxidation proceeds in high yield and selectivity, reducing the need for additional purification and correction steps.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method provides a more efficient and cost-effective route for synthesizing etonogestrel and desogestrel, potentially improving the manufacturing process for hormonal contraceptives by simplifying the synthesis steps and reducing production costs.

Implementation Method 1

wherein etonogestrel is obtained by deprotection of the 3-dithioacetal using periodic acid, thallium nitrate or stabilized 2-iodoxybenzoic acid (SIBX)

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 2

stabilized 2-iodoxybenzoic acid (SIBX) and β-cyclodextrin (β-CD)

Methodology Applied
Scientific EffectInclusion complexation: Absorption (physical)

Data Source

PatentEP2825547B1Combined synthesis route for etonogestrel and desogestrel
Publication Date: 2019.07.24 MERCK SHARP & DOHME BV
  • EP2825547B1 patent drawing
  • EP2825547B1 patent drawing
  • EP2825547B1 patent drawing

AI summary

The present invention relates to a synthesis route and to steroid derivatives of general formula VI and VII useful in the synthesis of desogestrel and etonogestrel.